Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Human prenatal skin develops an immune network early on that helps with skin formation and healing without scarring.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Caspases affect many cell functions and could help treat various diseases.

The document concludes that better understanding the wound microbiome can improve chronic wound care by preserving helpful bacteria and targeting harmful ones.

Astrotactin proteins are important for brain and skin development and are linked to several neurodevelopmental disorders.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

PINK1 is important for controlling gut immune responses linked to early Parkinson's disease.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

CD2 might be a new treatment target for patchy alopecia areata.

Researchers found four genes that could help diagnose severe alopecia areata early.

Blocking Rab27a slows hair growth, while blocking Rab27b encourages it.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Regulatory T cells help control the immune system and could lead to new treatments for diseases.

Next-generation Treg therapies could help achieve lasting immune tolerance in type 1 diabetes.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

More research is needed to understand and manage rheumatoid arthritis better.

HuR is essential for Treg function and preventing autoimmunity.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Single-cell engineered biotherapeutics show promise for skin treatment but need more research and trials.

CD4+ skin cells may be precursors to basal cell carcinoma.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.